Provided by Tiger Trade Technology Pte. Ltd.

Telos Corporation

4.68
+0.07001.52%
Post-market: 4.700.0200+0.43%19:54 EDT
Volume:493.63K
Turnover:2.31M
Market Cap:350.15M
PE:-21.69
High:4.79
Open:4.52
Low:4.52
Close:4.61
52wk High:8.36
52wk Low:3.79
Shares:74.82M
Float Shares:52.29M
Volume Ratio:0.78
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2157
EPS(LYR):-0.5015
ROE:-14.86%
ROA:-1.56%
PB:3.75
PE(LYR):-9.33

Loading ...

Northland Securities Keeps Their Buy Rating on Telos (TLS)

TIPRANKS
·
Jul 06

Telos Director Derrick D. Dockery Sells 7,000 Shares for $30,520

Reuters
·
Jun 27

What Telstra Group (ASX:TLS)'s Stronger Earnings and Capital Returns Mean For Shareholders

Simply Wall St.
·
Jun 26

Telos Director Bradley W. Jacobs Sells 55,772 Shares Worth $240,373.32

Reuters
·
Jun 25

Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window

GlobeNewswire
·
Jun 11

Should Telstra’s Connected Future 30 Capital Returns Strategy Require Action From Telstra Group (ASX:TLS) Investors?

Simply Wall St.
·
Jun 06

Telos - John B. Wood Returns as President, CEO and Chairman Effective May 28, 2026 - SEC Filing

THOMSON REUTERS
·
May 29

Telos director Derrick D. Dockery sells 8,000 shares for $38,240

Reuters
·
May 29

Telos CEO John Wood returns from medical leave, resumes chairman role

Reuters
·
May 29

Telos Corp Price Target Announced at $6.00/Share by Needham

Dow Jones
·
May 26

Calitri Initiates Telos With Buy Rating on Profitable Shift to High‑Margin Security Solutions and Double‑Digit Growth Potential

TIPRANKS
·
May 26

Telos Corp : Needham Reinstates Coverage With Buy Rating; Target Price $6

THOMSON REUTERS
·
May 26

These Cybersecurity Stocks Are Poised for Rapid Growth Through 2028, and Some of Them Are Cheap Right Now

Dow Jones
·
May 25

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

GlobeNewswire
·
May 22

2026 ASCO | Pivotal Data of InnoCare's Novel BCL2 Inhibitor Mesutoclax Released

GlobeNewswire
·
May 22

What Telstra Group (ASX:TLS)'s Dividend Uplift Outlook Means For Shareholders

Simply Wall St.
·
May 20

Telos director Derrick Dockery disposes 18,000 shares for $74,520

Reuters
·
May 16

Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights

GlobeNewswire
·
May 15

Analysts Offer Insights on Technology Companies: D-Wave Quantum (QBTS), Camtek (CAMT) and Telos (TLS)

TIPRANKS
·
May 13

Northland Securities Remains a Buy on Telos (TLS)

TIPRANKS
·
May 12